DEF 14A

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

September 19, 2022

Period of Report

September 19, 2022

Accession Number

0001005286-22-000054

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →